BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21813612)

  • 1. Crystal structures of enterovirus 71 3C protease complexed with rupintrivir reveal the roles of catalytically important residues.
    Wang J; Fan T; Yao X; Wu Z; Guo L; Lei X; Wang J; Wang M; Jin Q; Cui S
    J Virol; 2011 Oct; 85(19):10021-30. PubMed ID: 21813612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and anti-hand, foot, and mouth disease virus drug design.
    Lu G; Qi J; Chen Z; Xu X; Gao F; Lin D; Qian W; Liu H; Jiang H; Yan J; Gao GF
    J Virol; 2011 Oct; 85(19):10319-31. PubMed ID: 21795339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structures of Enterovirus 71 3C proteinase (strain E2004104-TW-CDC) and its complex with rupintrivir.
    Wu C; Cai Q; Chen C; Li N; Peng X; Cai Y; Yin K; Chen X; Wang X; Zhang R; Liu L; Chen S; Li J; Lin T
    Acta Crystallogr D Biol Crystallogr; 2013 May; 69(Pt 5):866-71. PubMed ID: 23633597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for antiviral inhibition of the main protease, 3C, from human enterovirus 93.
    Costenaro L; Kaczmarska Z; Arnan C; Janowski R; Coutard B; Solà M; Gorbalenya AE; Norder H; Canard B; Coll M
    J Virol; 2011 Oct; 85(20):10764-73. PubMed ID: 21835784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the Enterovirus 71 3C Protease in Complex with NK-1.8k and Indications for the Development of Antienterovirus Protease Inhibitor.
    Wang Y; Cao L; Zhai Y; Yin Z; Sun Y; Shang L
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Enterovirus 71 (EV71) Virulence Determinant: The 69th Residue of 3C Protease Modulates Pathogenicity.
    Li B; Yue Y; Zhang Y; Yuan Z; Li P; Song N; Lin W; Liu Y; Gu L; Meng H
    Front Cell Infect Microbiol; 2017; 7():26. PubMed ID: 28217559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of human enterovirus 71 3C protease.
    Cui S; Wang J; Fan T; Qin B; Guo L; Lei X; Wang J; Wang M; Jin Q
    J Mol Biol; 2011 May; 408(3):449-61. PubMed ID: 21396941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptidomimetic ethyl propenoate covalent inhibitors of the enterovirus 71 3C protease: a P2-P4 study.
    Ang MJ; Lau QY; Ng FM; Then SW; Poulsen A; Cheong YK; Ngoh ZX; Tan YW; Peng J; Keller TH; Hill J; Chu JJ; Chia CS
    J Enzyme Inhib Med Chem; 2016; 31(2):332-9. PubMed ID: 25792507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-3C Protease Inhibitor Rupintrivir Binds SARS-CoV-2 Main Protease in a Unique Binding Mode.
    Lockbaum GJ; Henes M; Lee JM; Timm J; Nalivaika EA; Thompson PR; Kurt Yilmaz N; Schiffer CA
    Biochemistry; 2021 Oct; 60(39):2925-2931. PubMed ID: 34506130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rupintrivir is a promising candidate for treating severe cases of Enterovirus-71 infection.
    Zhang XN; Song ZG; Jiang T; Shi BS; Hu YW; Yuan ZH
    World J Gastroenterol; 2010 Jan; 16(2):201-9. PubMed ID: 20066739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of the HRV-C 3C-Rupintrivir Complex Provides New Insights for Inhibitor Design.
    Yuan S; Fan K; Chen Z; Sun Y; Hou H; Zhu L
    Virol Sin; 2020 Aug; 35(4):445-454. PubMed ID: 32103448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor.
    Binford SL; Maldonado F; Brothers MA; Weady PT; Zalman LS; Meador JW; Matthews DA; Patick AK
    Antimicrob Agents Chemother; 2005 Feb; 49(2):619-26. PubMed ID: 15673742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro resistance study of rupintrivir, a novel inhibitor of human rhinovirus 3C protease.
    Binford SL; Weady PT; Maldonado F; Brothers MA; Matthews DA; Patick AK
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4366-73. PubMed ID: 17908951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and biochemical characterization of DC07090 as a novel potent small molecule inhibitor against human enterovirus 71 3C protease by structure-based virtual screening.
    Ma GH; Ye Y; Zhang D; Xu X; Si P; Peng JL; Xiao YL; Cao RY; Yin YL; Chen J; Zhao LX; Zhou Y; Zhong W; Liu H; Luo XM; Chen LL; Shen X
    Eur J Med Chem; 2016 Nov; 124():981-991. PubMed ID: 27776325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enterovirus 71 3C inhibits cytokine expression through cleavage of the TAK1/TAB1/TAB2/TAB3 complex.
    Lei X; Han N; Xiao X; Jin Q; He B; Wang J
    J Virol; 2014 Sep; 88(17):9830-41. PubMed ID: 24942571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into cleavage specificity from the crystal structure of foot-and-mouth disease virus 3C protease complexed with a peptide substrate.
    Zunszain PA; Knox SR; Sweeney TR; Yang J; Roqué-Rosell N; Belsham GJ; Leatherbarrow RJ; Curry S
    J Mol Biol; 2010 Jan; 395(2):375-89. PubMed ID: 19883658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The enterovirus protease inhibitor rupintrivir exerts cross-genotypic anti-norovirus activity and clears cells from the norovirus replicon.
    Rocha-Pereira J; Nascimento MS; Ma Q; Hilgenfeld R; Neyts J; Jochmans D
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4675-81. PubMed ID: 24890597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3.
    Lei X; Sun Z; Liu X; Jin Q; He B; Wang J
    J Virol; 2011 Sep; 85(17):8811-8. PubMed ID: 21697485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of enterovirus 71 replication and viral 3C protease by quercetin.
    Yao C; Xi C; Hu K; Gao W; Cai X; Qin J; Lv S; Du C; Wei Y
    Virol J; 2018 Jul; 15(1):116. PubMed ID: 30064445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes.
    Matthews DA; Dragovich PS; Webber SE; Fuhrman SA; Patick AK; Zalman LS; Hendrickson TF; Love RA; Prins TJ; Marakovits JT; Zhou R; Tikhe J; Ford CE; Meador JW; Ferre RA; Brown EL; Binford SL; Brothers MA; DeLisle DM; Worland ST
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11000-7. PubMed ID: 10500114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.